Schrodinger, Inc.(SDGR)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Schrodinger, Inc. (SDGR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SDGR at 33.0/100 on a 32-signal composite quality model, placing it at rank #2,403 of 2,960 stocks — the bottom half of the AI-ranked universe. SDGR scores in the top quartile across revenue growth (85.5). Areas of concern include earnings quality (1.3) and free cash flow (9.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 10.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Schrodinger, Inc. reports quarterly revenue of $58.9M, net income of $6.0M, an operating margin of -70.5%. Top institutional holders of SDGR by reported 13-F value include BlackRock, GATES FOUNDATION, Rubric Capital Management, based on the most recent SEC filings. SDGR trades on the Nasdaq exchange and files with the SEC under CIK 1490978. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SDGR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Schrodinger, Inc. directly from SEC EDGAR.

AI Quality Score

33.0/100

AI Rank

#2,403

Revenue

$58.9M

Net Income

$6.0M

Free Cash Flow

$-34.4M

Operating Margin

-70.5%

SDGR key financials by period

Schrodinger, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$255.9M$-103.3M-65.2%
FY 202410-K$207.5M$-187.1M-100.8%
FY 202310-K$216.7M$40.7M-81.9%
FY 202210-K$181.0M$-149.2M-81.1%
FY 202110-K$137.9M$-100.4M-80.8%
FY 202010-K$108.1M$-24.5M-56.4%

Institutions holding SDGR

Institutional investors reporting a position in Schrodinger, Inc. on SEC Form 13F.
InstitutionSharesValueReported
BlackRock10,521,724$171.0M2026-06-30
GATES FOUNDATION6,981,664$113.5M2026-06-30
Rubric Capital Management6,400,000$104.0M2026-06-30
VANGUARD PORTFOLIO MANAGEMENT3,787,391$61.5M2026-06-30
Sumitomo Mitsui2,706,143$44.0M2026-06-30
Nikko Asset Management Americas2,706,143$43.9M2026-06-30
VANGUARD CAPITAL MANAGEMENT2,691,149$43.7M2026-06-30
STATE STREET2,298,338$37.3M2026-06-30
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME2,221,485$36.1M2026-06-30
ARK Investment Management2,154,018$35.0M2026-06-30
SDGR

Schrodinger, Inc.

SDGR
NasdaqSmall CapHealthcare

13F Pro Quality Score

33.0/100

Rank #2,403 of 2,960 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

85.5/100

Profitability

17.5/100

Balance Sheet

18.9/100

Earnings Quality

1.3/100

Free Cash Flow

9.4/100

Institutional Flow

16.3/100

Revenue Scale

27.4/100

Dilution Risk

10.8/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$58.89M

Net Income

Q2 2026
EDGAR

$5.97M

EPS (Diluted)

Q2 2026
EDGAR

$0.08

Operating Margin

Q2 2026
EDGAR

-70.5%

ROIC

Q2 2026
EDGAR

-50.5%

Free Cash Flow

Q2 2026
EDGAR

$-34.43M

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…